Talmetacin

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C27H20ClNO6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6FY017I6S7, chemically known as 1,3-dihydro-3-oxo-1-isobenzofuranyl 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1h-indole-3-acetate but generally known as talmetacin, which bears US NIH Compound Identifier 68564. European Medicines Agency schedules Talmetacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10808MIG. The term TALMETACIN is an International Non-Proprietary Name. TALMETACIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule talmetacin under HS 29349990 and SITC 51579. As of Q4 2014, TALMETACIN remains the US FDA Preferred Term for this commodity. Talmetacin bears US NLM identifiers UMLS ID C2699883 and NCI Concept Code C76813. SMILES: CLC1CCC(C(=O)N2C(C(C3C2CCC(OC)C3)CC(=O)OC2OC(=O)C3C2CCCC3)C)CC1.